Skip to main content
SpringerLink
Log in

Nilotinib Induced Peripheral Artery Occlusive Disease

  • Chapter
  • First Online:
Clinical Cases in Cardio-Oncology

Part of the book series: Clinical Cases in Cardiology ((CCC))

  • 299 Accesses

Abstract

Patient was a 62-year-old male with CML on nilotinib, hypertension and hyperlipidemia, presented with intermittent claudication. He underwent CT angiogram which showed long-segment Trans-Atlantic Inter-Society (TASC) II D femoropopliteal occlusive disease. He underwent bypass surgery. After this, Nilotinib was stopped and switched to dasatinib 100 mg p.o. daily.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Quintás-Cardama A, Kantarjian H, Cortes J. Nilotinib-associated vascular events. Clin Lymphoma Myeloma Leuk. 2012;12(5):337–340.2012.04.005.

    Article  Google Scholar 

  2. Tefferi A, Letendre L. Nilotinib treatment-associated peripheral artery disease and sudden death: yet another reason to stick to imatinib as front-line therapy for chronic myelogenous leukemia. Am J Hematol. 2011;86(7):610–1. https://doi.org/10.1002/ajh.22051.

    Article  PubMed  Google Scholar 

  3. Aichberger KJ, Herndlhofer S, Schernthaner GH, et al. Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML. Am J Hematol. 2011;86(7):533–9. https://doi.org/10.1002/ajh.22037.

    Article  CAS  PubMed  Google Scholar 

  4. Porta-Sánchez A, Gilbert C, Spears D, et al. Incidence, diagnosis, and management of QT prolongation induced by cancer therapies: a systematic review. J Am Heart Assoc. 2017;6(12)

    Google Scholar 

  5. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45 Suppl:S5–S67.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Northern Ontario School of Medicine, Thunder Bay, ON, Canada

    Atooshe Rohani

Authors
  1. Atooshe Rohani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Atooshe Rohani .

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rohani, A. (2021). Nilotinib Induced Peripheral Artery Occlusive Disease. In: Clinical Cases in Cardio-Oncology. Clinical Cases in Cardiology. Springer, Cham. https://doi.org/10.1007/978-3-030-71155-9_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-71155-9_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-71154-2

  • Online ISBN: 978-3-030-71155-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation